China's anti-COVID drug Azvudine

China's anti-COVID drug Azvudine

Photo taken on Jan. 10, 2023, shows an assembly line for oral anti-COVID drug Azvudine at a factory of China Resources Double-Crane Pharmaceutical Co. in Beijing. The Chinese government unveiled the factory to the media amid rampant coronavirus infections in the country.

  • Product Code
  • ILEA001225438
  • Registered date
  • 2023/1/10 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2023 Kyodo News
  • Media size
  • 3304 × 2293 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 625.10(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    A Pharmaceutical Company in Chongqing

    A Pharmaceutical Company in Chongqing

    An employee is packing biological drugs at a packaging workshop at a pharmaceutical company in Chongqing, China, on March 6, 2024. (Photo by Costfoto/NurPhoto)
      A Pharmaceutical Company Workshop in Meishan

      A Pharmaceutical Company Workshop in Meishan

      A worker is working on a drug production line at the production workshop of a pharmaceutical company in Meishan, China, on January 30, 2024. (Photo by Costfoto/NurPhoto)
        A Pharmaceutical Company Workshop in Meishan

        A Pharmaceutical Company Workshop in Meishan

        A worker is working on a drug production line at the production workshop of a pharmaceutical company in Meishan, China, on January 30, 2024. (Photo by Costfoto/NurPhoto)
          A Pharmaceutical Company Workshop in Meishan

          A Pharmaceutical Company Workshop in Meishan

          A worker is working on a drug production line at the production workshop of a pharmaceutical company in Meishan, China, on January 30, 2024. (Photo by Costfoto/NurPhoto)
            A Pharmaceutical Company Workshop in Meishan

            A Pharmaceutical Company Workshop in Meishan

            A worker is working on a drug production line at the production workshop of a pharmaceutical company in Meishan, China, on January 30, 2024. (Photo by Costfoto/NurPhoto)
              A Pharmaceutical Company Workshop in Meishan

              A Pharmaceutical Company Workshop in Meishan

              A worker is working on a drug production line at the production workshop of a pharmaceutical company in Meishan, China, on January 30, 2024. (Photo by Costfoto/NurPhoto)
                A Pharmaceutical Company Workshop in Meishan

                A Pharmaceutical Company Workshop in Meishan

                A worker is working on a drug production line at the production workshop of a pharmaceutical company in Meishan, China, on January 30, 2024. (Photo by Costfoto/NurPhoto)
                  A Pharmaceutical Company Workshop in Meishan

                  A Pharmaceutical Company Workshop in Meishan

                  A worker is working on a drug production line at the production workshop of a pharmaceutical company in Meishan, China, on January 30, 2024. (Photo by Costfoto/NurPhoto)
                    A Pharmaceutical Company Workshop in Meishan

                    A Pharmaceutical Company Workshop in Meishan

                    A worker is working on a drug production line at the production workshop of a pharmaceutical company in Meishan, China, on January 30, 2024. (Photo by Costfoto/NurPhoto)
                      A Pharmaceutical Company Workshop in Meishan

                      A Pharmaceutical Company Workshop in Meishan

                      A worker is working on a drug production line at the production workshop of a pharmaceutical company in Meishan, China, on January 30, 2024. (Photo by Costfoto/NurPhoto)